Effects of Danazol on Clinical Improvement of Patients with Human T-cell Lymphotropic Virus Type I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Placebo-Controlled Clinical Trial

Objective(s): Human T-Cell Lymphotropic Virus Type I (HTLV-I) associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an endemic disease observed in Japan, Africa, Caribbean basin, and north-east Iran. It is usually presented as a chronic and progressive spastic paraparesis. There are some o...

Descripción completa

Detalles Bibliográficos
Autores principales: Boostani, Reza, Saber, Hamidreza, Etemadi, Mohammadmahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881241/
https://www.ncbi.nlm.nih.gov/pubmed/24470864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881241/
https://www.ncbi.nlm.nih.gov/pubmed/24470864

Ejemplares similares